Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IMCR
IMCR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMCR News
Immunocore Announces R&D Leadership Changes
Jan 30 2026
Newsfilter
Immunocore to Showcase at Upcoming Investor Events
Nov 10 2025
Newsfilter
HC Wainwright & Co. Affirms Buy Rating for Immunocore Holdings, Keeps $100 Price Target Intact
Oct 22 2025
Benzinga
H.C. Wainwright Maintains Positive Outlook on Immunocore Holdings plc (IMCR)
Oct 21 2025
Yahoo Finance
Resolution Therapeutics names Lucy Singah as CFO and Daniel Kennedy as CBO
Sep 10 2025
Newsfilter
Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
Aug 09 2025
Newsfilter
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Aug 08 2025
NASDAQ.COM
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
Aug 06 2025
NASDAQ.COM
HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
Aug 06 2025
NASDAQ.COM
BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark
Aug 06 2025
NASDAQ.COM
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
Jun 30 2025
Globenewswire
FDA Extends INCY's Application for Opzelura Label Expansion
Jun 23 2025
NASDAQ.COM
CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech
Jun 20 2025
NASDAQ.COM
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews
Jun 02 2025
Benzinga
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target
Jun 02 2025
Benzinga
Mizuho Maintains Neutral on Immunocore Holdings, Lowers Price Target to $33
Apr 07 2025
Benzinga
Show More News
